RARE icon

Ultragenyx Pharmaceutical (RARE)

NASDAQ

$23.39

$0.37 (

+1.61%

)

1D
5D
1M
6M
1Y
5Y
Market closed

RARE: $23.39 / ₿ 0.0003 BTC / 34566 Sats

1D
5D
1M
6M
1Y
5Y

Key statistics

$23.02
$18.41 - $43.22
$2.26B
-0.83
$23.00
$1,405,263.33
96.63M
$19.40 - $32.00
$22.82 - $23.44
Yes

What is Ultragenyx Pharmaceutical (RARE)?

Ultragenyx Pharmaceutical Inc is a USA-based biopharmaceutical company. The company identifies, acquires, develops, and commercializes novel products for the treatment of serious, rare, and ultra-rare diseases, with a focus on debilitating genetic conditions. Its medicine portfolio includes Crysvita, Dojolvi, and Mepsevii. Crysvita is indicated for the treatment of X-linked hypophosphatemia (XLH) in adult and pediatric patients aged one year and older. Mepsevii is indicated for pediatric and adult patients for the treatment of Mucopolysaccharidosis VII. The company operates across North America, Latin America, Europe, the Middle East and Africa, and Asia-Pacific, with the majority of its revenue generated from North America.

The Ultragenyx Pharmaceutical (RARE) stock price has been rising

The Ultragenyx Pharmaceutical Inc. Common Stock (RARE) stock price today is $23.39, reflecting a +1.61% move since the market opened. The company’s market capitalization stands at $2.26B, with a daily trading volume of $1.41M shares. For investors tracking price trends, Ultragenyx Pharmaceutical Inc. Common Stock stock has ranged between $22.82 and $23.44 today. The previous closing price was $23.02.

Get started with Ultragenyx Pharmaceutical (RARE)

Ready to get started? Follow the steps below, or read our guide on how to buy Ultragenyx Pharmaceutical stock on Kraken starting from $10.

Create an account

Create an account

Open the Kraken app to confirm your eligibility and follow the steps for account verification.



Deposit funds

Deposit funds

Once your account has been verified and stock trading is unlocked, you can deposit funds into your account using your preferred payment method.

Buy

Buy RARE

Search for RARE in the Kraken app, enter the amount you want to invest, review the important details and tap Confirm to place an order to buy RARE.

RARE FAQs

RARE is in the Healthcare sector. Sector is a broad classification that groups companies based on their business activities, industry focus or economic function.

RARE is in the Biotechnology industry. Industry is a more specific classification within a sector, grouping companies that operate in a similar field and have closely related business models.

Over the past 52 weeks, Ultragenyx Pharmaceutical Inc. Common Stock (RARE) has traded between a low of $18.41 and a high of $43.22.

RARE is in the Biotechnology industry group. Industry group is a further subdivision within an industry, grouping companies with even more closely related business models and operations. This helps investors analyze stocks at a more detailed level than sector and industry classifications alone.

Want to invest in Ultragenyx Pharmaceutical? 
Get the Kraken app

Eligible US clients can now invest in over 11,000 stocks and ETFs - commission-free* - directly in the Kraken app. Download it and get started.

Fictional stock
USD icon
USD
RARE icon
RARE

Only available to USA clients through the Kraken app
or Kraken Pro.

Get the Kraken Pro app and buy Ultragenyx Pharmaceutical in minutes

Kraken App QR Code

Explore other stocks

Most active

Explore the most-traded stocks today

Top gainers

Browse today’s biggest stock market winners

Top losers

Compare the worst-performing stocks of 
the day

OTRKQ icon

OTRKQ

YOTAR icon

YOTAR

CRESW icon

Want to learn more about equities?

Check out our Kraken Learn Center guides

Currently available in the U.S. only; may not be available in all states. Brokerage services are provided by Kraken Securities LLC, member FINRA/SIPC. Please view the firm’s profile, registration and background of our registered reps on https://brokercheck.finra.org/. Digital asset services offered by Payward Interactive, not a member of FINRA/ SIPC and not FDIC insured. This is not an offer, solicitation, inducement or advice to buy or sell securities, or open a brokerage account in any jurisdiction where Kraken Securities is not registered. All trading involves risk, including loss of your investments. View full disclosures at: Equities Disclosures and Crypto Risk Disclosures.

*Other applicable fees may apply.